{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:20:21Z","timestamp":1784683221470,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":714,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.repc.2016.09.012","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T17:01:18Z","timestamp":1492880478000},"page":"385-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cochrane Corner: efic\u00e1cia anti\u2010hipertensora dos betabloqueadores seletivos beta\u20101 na hipertens\u00e3o essencial"],"prefix":"10.1016","volume":"36","author":[{"given":"Lu\u00eds","family":"Nogueira\u2010Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Sousa","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2016.09.012_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007451.pub2","article-title":"Blood pressure lowering efficacy of beta\u20101 selective beta blockers for primary hypertension","author":"Wong","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.repc.2016.09.012_bib0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.repc.2016.09.012_bib0065","article-title":"Blood pressure lowering efficacy of nonselective beta\u2010blockers for primary hypertension","author":"Wong","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.repc.2016.09.012_bib0070","article-title":"Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension","author":"Wong","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.repc.2016.09.012_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007449.pub2","article-title":"Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension","author":"Wong","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.repc.2016.09.012_bib0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1185\/03007995.2015.1013624","article-title":"Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis","volume":"31","author":"Chen","year":"2015","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.repc.2016.09.012_bib0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/1060028013519591","article-title":"\u03b2\u2010blockers: a review of their pharmacological and physiological diversity in hypertension","volume":"48","author":"Ripley","year":"2014","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.repc.2016.09.012_bib0090","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens."},{"key":"10.1016\/j.repc.2016.09.012_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta\u2010analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med."},{"key":"10.1016\/j.repc.2016.09.012_bib0100","article-title":"Beta\u2010blockers for hypertension","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117300148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255117300148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:05:07Z","timestamp":1760108707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255117300148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0870255117300148"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2016.09.012","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cochrane Corner: efic\u00e1cia anti\u2010hipertensora dos betabloqueadores seletivos beta\u20101 na hipertens\u00e3o essencial","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}